Postmarketing experience with brivaracetam in the treatment of epilepsies: A multicenter cohort study from Germany

Randomized controlled antiepileptic drug trials miss almost all patients with ongoing seizures

(2017) Bernhard J. Steinhoff et al.   EPILEPSY & BEHAVIOR

Treatment of refractory and super-refractory status epilepticus with brivaracetam: A cohort study from two German university hospitals

(2017) Adam Strzelczyk et al.   EPILEPSY & BEHAVIOR

Eslicarbazepine acetate: its effectiveness as adjunctive therapy in clinical trials and open studies

(2017) S. D. Shorvon et al.   JOURNAL OF NEUROLOGY

Eslicarbazepine acetate as a therapeutic option in a patient with carbamazepine-induced rash and HLA-A*31:01

(2017) Lara Kay et al.   SEIZURE-EUROPEAN JOURNAL OF EPILEPSY

Evidence for a differential interaction of brivaracetam and levetiracetam with the synaptic vesicle 2A protein

(2016) Martyn D. Wood et al.   EPILEPSIA

Adjunctive retigabine in refractory focal epilepsy: Postmarketing experience at four tertiary epilepsy care centers in Germany

(2016) R.D. Nass et al.   EPILEPSY & BEHAVIOR

Efficacy and safety of brivaracetam for partial-onset seizures in 3 pooled clinical studies

(2016) Elinor Ben-Menachem et al.   NEUROLOGY

Brivaracetam in the treatment of focal and idiopathic generalized epilepsies and of status epilepticus

(2016) Adam Strzelczyk et al.   Expert Review of Clinical Pharmacology

Anti-ictogenic and antiepileptogenic properties of brivaracetam in mature and immature rats

(2015) Nina Dupuis et al.   EPILEPSIA

A randomized, double-blind, placebo-controlled, multicenter, parallel-group study to evaluate the efficacy and safety of adjunctive brivaracetam in adult patients with uncontrolled partial-onset seizures

(2015) Pavel Klein et al.   EPILEPSIA

Brivaracetam augments short-term depression and slows vesicle recycling

(2015) Xiaofeng Yang et al.   EPILEPSIA

An open-label, prospective, exploratory study of patients with epilepsy switching from levetiracetam to brivaracetam

(2015) Stephen L. Yates et al.   EPILEPSY & BEHAVIOR

Brivaracetam Differentially Affects Voltage-Gated Sodium Currents Without Impairing Sustained Repetitive Firing in Neurons

(2014) Isabelle Niespodziany et al.   CNS Neuroscience & Therapeutics

ILAE Official Report: A practical clinical definition of epilepsy

(2014) Robert S. Fisher et al.   EPILEPSIA

A multicenter survey of clinical experiences with perampanel in real life in Germany and Austria

(2014) Bernhard J. Steinhoff et al.   EPILEPSY RESEARCH

Brivaracetam as adjunctive treatment for uncontrolled partial epilepsy in adults: A phase III randomized, double-blind, placebo-controlled trial

(2013) Victor Biton et al.   EPILEPSIA

Adjunctive brivaracetam for uncontrolled focal and generalized epilepsies: Results of a phase III, double-blind, randomized, placebo-controlled, flexible-dose trial

(2013) Patrick Kwan et al.   EPILEPSIA

Adjunctive brivaracetam in adults with uncontrolled focal epilepsy: Results from a double-blind, randomized, placebo-controlled trial

(2013) Philippe Ryvlin et al.   EPILEPSIA

Long-term retention of lacosamide in a large cohort of people with medically refractory epilepsy: A single centre evaluation

(2013) Jan Novy et al.   EPILEPSY RESEARCH

Clinical experience with oral lacosamide as adjunctive therapy in adult patients with uncontrolled epilepsy: A multicentre study in epilepsy clinics in the United Kingdom (UK)

(2012) Lorena Flores et al.   SEIZURE-EUROPEAN JOURNAL OF EPILEPSY

Relationship of clinical and quality of life trajectories following the onset of seizures: Findings from the UK MESS Study

(2011) Ann Jacoby et al.   EPILEPSIA

Remission and relapse in a drug-resistant epilepsy population followed prospectively

(2011) Brian Callaghan et al.   EPILEPSIA

The long-term retention of zonisamide in a large cohort of people with epilepsy at a tertiary referral centre

(2011) Claudia B. Catarino et al.   EPILEPSY RESEARCH

Risk of sudden unexpected death in epilepsy in patients given adjunctive antiepileptic treatment for refractory seizures: a meta-analysis of placebo-controlled randomised trials

(2011) Philippe Ryvlin et al.   LANCET NEUROLOGY

Drug-Resistant Epilepsy

(2011) Patrick Kwan et al.   NEW ENGLAND JOURNAL OF MEDICINE

Anti-convulsive and anti-epileptic properties of brivaracetam (ucb 34714), a high-affinity ligand for the synaptic vesicle protein, SV2A

(2008) A Matagne et al.   BRITISH JOURNAL OF PHARMACOLOGY

Effect of brivaracetam on cardiac repolarisation – a thorough QT study

(2008) D. Rosillon et al.   CURRENT MEDICAL RESEARCH AND OPINION

Cost of Epilepsy

(2008) Adam Strzelczyk et al.   PHARMACOECONOMICS